Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Pharmacology Research & Perspectives|February 22, 2022
Why is motilin active in some studies with mice, rats, and guinea pigs, but not in others? Implications for functional variability among rodentsGareth J SangerBritish Journal of Pharmacology|March 17, 2004
Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and painGareth J SangerTrends in Pharmacological Sciences|December 17, 2008
5-hydroxytryptamine and the gastrointestinal tract: where next?Gareth J SangerDrug Discovery Today|March 18, 2008
Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseasesGareth J SangerCurrent Opinion in Pharmacology|August 4, 2012
Motilin receptor neuropharmacology: revised understandingGareth J SangerExperimental and Molecular Pathology|August 18, 2024
Age-related decline in goblet cell numbers and mucin content of the human colon: Implications for lower bowel functions in the elderlyNicholas Baidoo, Gareth J SangerBritish Journal of Pharmacology|November 30, 2012
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycinJohn Broad, Gareth J SangerBritish Journal of Hospital Medicine (London, England : 2005)|July 24, 2025
The Ageing of the Human Lower BowelNicholas Baidoo, Gareth J SangerNeurogastroenterology and Motility|June 18, 2024
The human colon: Evidence for degenerative changes during aging and the physiological consequencesNicholas Baidoo, Gareth J SangerEuropean Journal of Pharmacology|July 10, 2023
Characterization of rat gastric myogenic contractions and modulation by oxytocin and arginine-vasopressinRaj Makwana, Gareth J SangerPageof 9